Search hospitals > Minnesota > Rochester
Mayo Clinic Cancer Center
Claim this profileRochester, Minnesota 55905
Global Leader in Breast Cancer
Global Leader in Lymphoma
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Leukemia
698 reported clinical trials
12 medical researchers
Summary
Mayo Clinic Cancer Center is a medical facility located in Rochester, Minnesota. This center is recognized for care of Breast Cancer, Lymphoma, Lung Cancer, Cancer, Leukemia and other specialties. Mayo Clinic Cancer Center is involved with conducting 698 clinical trials across 296 conditions. There are 12 research doctors associated with this hospital, such as Amit Mahipal, MD, Sani Kizilbash, MD, MPH, Marcus Noel, MD, and Robert McWilliams, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
2Lymphoma
Global LeaderStage IV
Stage II
CD20
Top PIs
Amit Mahipal, MDMayo Clinic3 years of reported clinical research
Studies Cancer
Studies Bile Duct Cancer
19 reported clinical trials
36 drugs studied
Sani Kizilbash, MD, MPHMayo Clinic in Rochester2 years of reported clinical research
Studies Glioblastoma
Studies Brain Cancer
12 reported clinical trials
22 drugs studied
Marcus Noel, MDMedStar Georgetown University Hospital4 years of reported clinical research
Studies Cervical Adenocarcinoma
Studies Pancreatic Cancer
12 reported clinical trials
23 drugs studied
Robert McWilliams, MDMayo Clinic in Rochester4 years of reported clinical research
Studies Pancreatic Cancer
Studies Melanoma
7 reported clinical trials
16 drugs studied
Clinical Trials running at Mayo Clinic Cancer Center
Adult T-Cell Leukemia/Lymphoma
Hairy Cell Leukemia
Cervical Adenocarcinoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Cancer
Pancreatic Cancer
Lung Cancer
Chronic Myelomonocytic Leukemia
Vemurafenib + Obinutuzumab vs Cladribine + Rituximab
for Hairy Cell Leukemia
The researchers are doing this study to compare the safety of vemurafenib in combination with obinutuzumab to the standard of approach of cladribine in combination with rituximab. The researchers will look at which treatment causes fewer or milder side effects. Researchers think vemurafenib and obinutuzumab (non-chemotherapy drugs) may cause fewer side effects compared with the usual approach of chemotherapy drugs. They will also compare the two approaches to see which approach is more effective at eliminating cancer cells.
Recruiting1 award Phase 26 criteria
Cedazuridine + Azacitidine
for Leukemia
This trial tests a new pill form of two drugs, cedazuridine and azacitidine, for patients needing azacitidine treatment. The goal is to see if the pill is as effective as the injection. Cedazuridine helps azacitidine work better by preventing its breakdown, and azacitidine stops cancer cells from growing.
Recruiting1 award Phase 2 & 314 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mayo Clinic Cancer Center?
Where is Mayo Clinic Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Mayo Clinic Cancer Center accept?
What awards or recognition has Mayo Clinic Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.